MEC Basic Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Basic Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Everything « 1 … 14 15 16 17 18 … 62 » CT-guided Interventions: Reduction of Needle Tip Beam Hardening Artifact with Low Atomic Number Materials in a Phantom and Porcine Model Allison Couillard, MD View PDF Radioembolization for recurrent HCC following transplantation Robert Lewandowski, MD View PDF Decrease in tissue resistance during IRE Pancreas Hester Scheffer, MD View PDF Palliation for the Pancreatic Cancer Patient Thomas Scagnelli, MD View PDF Combined Approach to IRE Pancreas Praveen Peddu, MD View PDF Over a Decade of Percutaneous IRE of the Pancreas Martijn Meijerink, MD, PhD View PDF Optimizing patient selection for IRE Rob Martin II, MD, PhD View PDF Outcomes following MR guided ablation for LAPC Michael Chuong, MD View PDF Treatment strategies for borderline resectable patients Peter Hosein, MD View PDF Surgery for pancreatic cancer and working with a multidisciplinary team Horacio Asbun, MD View PDF HOPE 4 Kidney (Renal Histotripsy) Tze Min Wah, MBChB, PhD View PDF Choosing the right ablation option Kamran Ahrar, MD View PDF Role of Embolization in RCC Andrew Niekamp, MD View PDF Nephrectomy vs Partial resection vs Ablation Jorge Caso, MD View PDF Focal therapy options in Prostate Cancer Murugesan Manoharan, MD View PDF Urology and IR working together – the NIH Experience Brad Wood, MD View PDF Aiming for Better Outcomes: Comparing and Combining Systemic & Locoregional Therapies Yilun Koethe, MD View PDF Percutaneous ablation strategies in Cholangiocarcinoma Nadine Abi-Jaoudeh, MD View PDF How to incorporate molecular testing in therapy for localized disease Flavio Rocha, MD View PDF Locoregional treatments in Cholangiocarcinoma William Rilling, MD View PDF Current systemic treatments – Chemotherapy, Immunotherapy & Target Agents Caio Max Rocha Lima, MD View PDF 3rd Annual James G. Caridi Lecture Alda Tam, MD View PDF Y90 in locally-advanced disease with PVT Siddarth Padia, MD View PDF Advances in DEB-TACE technology and clinical outcomes Katerina Malagari, MD View PDF Impact of c-TACE on the management of HCC Jeff Geschwind, MD View PDF Ablation with a curative intent in HCC Fred T. Lee, MD View PDF Navigating locoregional treatment options in HCC Beau Toskich, MD View PDF Time to Transplant – An important factor in selection of liver directed therapy Jafar Golzarian, MD View PDF Revisiting the indications for Surgery vs Ablation David Levi, MD View PDF Role of genomics, molecular biomarkers and AI in HCC therapy Sarah White, MD View PDF
